01.17.2025
Ceva Acquires Touchlight
Stonehaven Cozmix Group (SC Group) congratulates Touchlight and CEVA SANTE ANIMALE on the successful completion of Ceva's acquisition of the rights to Touchlight's dbDNA technology for use in animal health. This partnership combines Ceva's world-leading expertise in development and commercialization of cutting-edge animal health products with Touchlight's groundbeaking dbDNA technology, which enables the rapid, high-purity enzymatic production of DNA while eliminating antibiotic resistance genes.
Congratulations also to Stonehaven Transactions, our M&A advisory division led by Dr Beatrice Vos, for acting as the exclusive transaction adviser to Touchlight and playing a key role in ensuring the success of the deal. To learn more about Stonehaven Transactions and our range of services, please feel free to contact Dr Beatrice Vos.
Contact Us
Matthias Hofer
Managing Partner
Beatrice Vos
Partner,
SC Transactions
Contact Us
Matthias Hofer
Managing Partner
Beatrice Vos
Partner,
SC Transactions
Related Articles
Kansas City Summit Investor Panel
We’re thrilled to share that our CEO & Managing Partner, Matthias Hofer, will be moderating the “How Animal Health Innovators Can Fund, Partner and Scale” investor panel at the Animal Health Corridor Summit 2026.
Stonehaven Cozmix July Promotions
We are delighted to announce four well-deserved promotions within our consulting team
Interview with Fabian Kausche
In our latest Leaders in Animal Health interview, Fabian reflects on a remarkable journey that has taken him from veterinary student
